Abstract:OBJECTIVE: Depressive symptoms and cognitive dysfunction are common in patients with schizophrenia and depressive disorder. This study aimed at exploring whether and how depressive symptoms were correlated with neuro-cognitive impairment in patients with never-treated first-episode (NTFE) schizophrenia.METHODS: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was administered to 79 patients and 80 healthy controls to assess neuropsychological function. For all patients, the 17-item Hamilton Depression Rating Scale (HAMD-17) was adopted to evaluate depressive symptoms, and the Positive and Negative Syndrome Scale (PANSS) was utilized to assess psychopathological symptoms.RESULTS: Thirty-nine patients (49.37%) met the criteria for comorbid depressive symptoms. The RBANS total and the four index scores in the patients were significantly lower than those in the healthy controls. Further, compared with patients without depressive symptoms, patients with depressive symptoms scored lower in attention index, but higher in PANSS general psychopathology and total scores. The HAMD-17 total score was significantly correlated with attention, PANSS total, and PANSS general psychopathology scores. Moreover, multiple regression analysis identified education and HAMD-17 score as the contributors to attention.CONCLUSION: Our results suggest that the rate of depressive symptoms in NTFE schizophrenia is high, which is correlated with neuro-cognitive impairment, especially attention and psychopathology.

What problem does this paper attempt to address?

This paper attempts to explore the relationship between depressive symptoms and neurocognitive impairment in first - episode schizophrenia patients who have never received treatment. Specifically, the study aims to: 1. **Explore the differences in neurocognitive performance between first - episode schizophrenia (NTFE SCZ) patients who have never received treatment with and without depressive symptoms**. 2. **Examine the correlation between depressive symptoms and neurocognitive deficits in NTFE SCZ patients**. The study hypothesizes that if schizophrenia patients have depressive symptoms, their neurocognitive performance will be worse, and depressive symptoms are related to neurocognitive impairment, independent of clinical symptoms (mainly negative and positive symptoms). ### Research Background - **Depressive Symptoms**: They are relatively common in schizophrenia patients and may have a serious impact on patients' social function and quality of life. - **Cognitive Deficits**: One of the core features of schizophrenia, covering multiple cognitive domains such as learning and memory, attention, and executive function. - **Existing Research**: Although some studies have shown that depressive symptoms are related to cognitive dysfunction, these studies mainly focus on chronic schizophrenia patients, and there are fewer studies on untreated first - episode patients. ### Main Findings 1. **Prevalence of Depressive Symptoms**: In untreated first - episode schizophrenia patients, the prevalence of depressive symptoms is 49.37%, significantly higher than that in chronic schizophrenia patients. 2. **Neurocognitive Performance**: - Compared with the healthy control group, patients showed significant neurocognitive deficits in attention, language, immediate memory, and total score. - Compared with patients without depressive symptoms, patients with depressive symptoms performed worse in attention. 3. **Correlation Analysis**: - The severity of depressive symptoms is negatively correlated with attention performance. - Educational level and the total score of HAMD - 17 are the main factors affecting attention. ### Conclusions - **Depressive Symptoms**: They are relatively common in untreated first - episode schizophrenia patients and are related to neurocognitive impairment (especially attention). - **Independence**: The relationship between depressive symptoms and neurocognitive impairment is independent of clinical symptoms, especially negative and positive symptoms. - **Future Research Directions**: Further longitudinal studies are needed to clarify the causal relationship between depressive symptoms and neurocognitive dysfunction. Through these findings, the study emphasizes the importance of early identification and intervention of depressive symptoms to improve the cognitive function and overall prognosis of schizophrenia patients.

Association of depressive symptoms with cognitive impairment in patients with never-treated first-episode schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study

565 – Abnormality of White Matter Structure and Resting State Brain Function in First-Episode, Treatment-Naive Patients with Major Depressive Disorder

Gender Differences of Schizophrenia Patients with and Without Depressive Symptoms in Clinical Characteristics.

Relationship Between Negative Symptoms and Neurocognitive Functions in Adolescent and Adult Patients with First-Episode Schizophrenia

Association of negative symptoms with cognitive impairment in Chinese Han patients with chronic schizophrenia

Altered Fractional Amplitude of Low Frequency Fluctuation Associated with Cognitive Dysfunction in First-Episode Drug-Naïve Major Depressive Disorder Patients

Cognitive Impairments in First-Episode Drug-Naive and Chronic Medicated Schizophrenia: MATRICS Consensus Cognitive Battery in a Chinese Han Population.

Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia

Neurocognitive profiles of patients with first-episode and recurrent depression: a cross-sectional comparative study from China

Twenty-Five Cohorts of Major Depressive Disorder in China: Evidence for Reduced But Not Enhanced Default Mode Network Functional Connectivity

Disrupted Intrinsic Functional Connectivity of the Cognitive Control Network Underlies Disease Severity and Executive Dysfunction in First-Episode, Treatment-Naive Adolescent Depression.

P50 sensory gating, cognitive deficits and depressive symptoms in first-episode antipsychotics-naïve schizophrenia

Prevalence of Neuropsychiatric Symptoms Across the Declining Memory Continuum: an Observational Study in a Memory Clinic Setting

Analysis of the status quo and clinical influencing factors of the social cognitive impairment in deficit schizophrenia

Cognitive function characteristics and influencing factors in patients with depressive disorders: a 5-year follow-up report based on the epidemiological survey of mental disorders in Shandong Province, China

Depressive symptoms in first-episode schizophrenia:A 9-year follow-up study

Association of empathy with clinical symptoms and cognitive function in Chinese chronic schizophrenia patients with and without deficit syndrome

Prevalence, Influencing Factors, and Cognitive Characteristics of Depressive Symptoms in Elderly Patients with Schizophrenia

The Comparison of Impairment of Cognitive Function in First-Episode Schizophrenia, Bipolar Disorder and Major Depressive Disorder

Depressive symptom mediates the association between the number of chronic diseases and cognitive impairment: a multi-center cross-sectional study based on community older adults

Sex Differences in the Association Between Symptom Profiles and Cognitive Functioning in Patients with Depressive Disorder